RANI - Rani Therapeutics Holdings Inc.: The Winning Streak Continues (RANI)
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) traded today at a new 52-week high of $36.00. This new high was reached on above average trading volume as 881,000 shares traded hands, while the average 30-day volume is approximately 65,000 shares.
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) defies analysts with a current price ($32.50) 24.1% above its average consensus price target of $24.65.
In the past 52 weeks, Rani Therapeutics Holdings Inc. share prices are bracketed by a low of $9.24 and a high of $36.00 and is now at $32.50, 252% above that low price.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer